B.A.Sc., Sc.D. (MIT), P.Eng.
University Professor and Michael E. Charles Chair in Chemical Engineering, Dept. of Chemical Engineering and Applied Chemistry, and Institute of Biomaterials and Biomedical Engineering, University of Toronto.
Phone: (416) 978-3088
Fax: (416) 978-4317
Biomaterials, Tissue engineering, Controlled release and drug delivery systems, Medical devices.
Technical advice on biomaterials, drug delivery systems an pharmaceutical formulations. Patent disputes
Professor Michael V. Sefton is Director of the Institute of Biomaterials and Biomedical Engineering at the University of Toronto . He is also a Professor in the Department of Chemical Engineering and Applied Chemistry, University of Toronto was educated at the University of Toronto (B.A.Sc., 1971) and at M.I.T. (Sc.D., 1974). He has been at the University of Toronto since 1974. He was Acting Chair of the Department of Chemical Engineering and Applied Chemistry in 1994 (Jan-June).
He is the 1992 recipient of the teaching award of the Faculty of Applied Science and Engineering. In 1988, he was awarded the Albright and Wilson Americas Award of the Canadian Society for Chemical Engineering (CSChE) in recognition of his contributions to research on the application of chemical engineering principles to medical problems, especially related to his pioneering efforts in tissue engineering and biomaterials. He was one of 20 given a Century of Achievement Award by the CSChE in 1999. He was awarded the Clemson Award of the Society for Biomaterials (US) for Basic Research in 1993. He is a foreign Fellow of the American Institute of Medical and Biological Engineering and a Fellow of the Chemical Institute of Canada and of Biomaterials Science and Engineering. He was recently a member of the Surgery and Bioengineering Study Section of the U.S. National Institutes of Health.
His consulting activities are related to his reseaserch program which is centered on the premise that biomaterials and biomaterial based devices are agaonists of biological responses akin to the action of small molecule drugs. The biological responses of particular interest include angiogenesis (blood vessel growth), thrombogenicity (blood ‘coagulation’), inflammation and immune responses.
Complete CV available upon request.